Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases].
Torizuka K, Uemura K, Toru M, Shinohara Y, Nishimura T, Yonekura Y, Nakagawara J, Matsuda H, Sakai F, Matsuda K, Fukuyama H, Morimoto K. Torizuka K, et al. Among authors: matsuda h, matsuda k. Kaku Igaku. 1996 Mar;33(3):329-44. Kaku Igaku. 1996. PMID: 8622266 Clinical Trial. Japanese.
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases].
Torizuka K, Uemura K, Toru M, Shinohara Y, Nishimura T, Yonekura Y, Nakagawara J, Matsuda H, Sakai F, Matsuda K, Fukuyama H, Morimoto K. Torizuka K, et al. Among authors: matsuda h, matsuda k. Kaku Igaku. 1996 Mar;33(3):293-301. Kaku Igaku. 1996. PMID: 8622263 Clinical Trial. Japanese.
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
Torizuka K, Uemura K, Toru M, Shinohara Y, Nishimura T, Yonekura Y, Nakagawara J, Matsuda H, Sakai F, Matsuda K, Fukuyama H, Morimoto K. Torizuka K, et al. Among authors: matsuda h, matsuda k. Kaku Igaku. 1996 Mar;33(3):303-18. Kaku Igaku. 1996. PMID: 8622264 Clinical Trial. Japanese.
Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.
Takeuchi R, Matsuda H, Yonekura Y, Sakahara H, Konishi J. Takeuchi R, et al. Among authors: matsuda h. J Cereb Blood Flow Metab. 1997 Oct;17(10):1020-32. doi: 10.1097/00004647-199710000-00003. J Cereb Blood Flow Metab. 1997. PMID: 9346426 Clinical Trial.
4,660 results